Cargando…
Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer
Aspirin prevents cardiovascular disease and colon cancer; however aspirin's inhibition of platelet COX-1 only partially explains its diverse effects. We previously identified an aspirin response signature (ARS) in blood consisting of 62 co-expressed transcripts that correlated with aspirin'...
Autores principales: | Voora, Deepak, Rao, A. Koneti, Jalagadugula, Gauthami S., Myers, Rachel, Harris, Emily, Ortel, Thomas L., Ginsburg, Geoffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049978/ https://www.ncbi.nlm.nih.gov/pubmed/27566955 http://dx.doi.org/10.1016/j.ebiom.2016.08.021 |
Ejemplares similares
-
Defective RAB31-mediated megakaryocytic early endosomal trafficking of VWF, EGFR, and M6PR in RUNX1 deficiency
por: Jalagadugula, Gauthami, et al.
Publicado: (2022) -
Influence of Sex on Platelet Reactivity in Response to Aspirin
por: Friede, Kevin A., et al.
Publicado: (2020) -
Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction
por: Rose, Jason J., et al.
Publicado: (2015) -
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015) -
Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events
por: Wingrove, James A., et al.
Publicado: (2018)